Pure Bioscience, Inc. (PURE) Reports Q1 Loss of $0.02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Price: $0.08 +14.29%
Financial Fact:
Total other income (expense): 768K
Today's EPS Names:
CFFI, ZGN, SSNC, More
Financial Fact:
Total other income (expense): 768K
Today's EPS Names:
CFFI, ZGN, SSNC, More
Join SI Premium – FREE
Pure Bioscience, Inc. (OTC: PURE) reported Q1 EPS of ($0.02). Revenue for the quarter came in at $489 thousand, versus $0 reported last year.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- Citizens Upgrades Omega Healthcare Investors (OHI) to Market Outperform
- Sonoco (SON) Misses Q3 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
